Flower City Capital Precigen, Inc. Transaction History

Flower City Capital

$185 Million
Q3 2025

A detailed history of Flower City Capital transactions in Precigen, Inc. stock. As of the latest transaction made, Flower City Capital holds 20,000 shares of PGEN stock, worth $83,200. This represents 0.04% of its overall portfolio holdings.

Number of Shares

20,000

Holding current value

$83,200

% of portfolio

0.04%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2025 Oct 08, 2025	BUY	$1.43 - $4.76 $28,600 - $95,200	20,000 New	20,000 $65,000
Q4 2023 Jan 19, 2024	BUY	$0.89 - $1.41 $8,900 - $14,100	10,000 New	10,000 $13,000

Others Institutions Holding PGEN

# of Institutions

166

Shares Held

166M

Call Options Held

511K

Put Options Held

Third Security, LLC

83.5M
Shares

$347 Million
73.5% of portfolio
Patient Capital Management, LLC Baltimore, MD

16.3M
Shares

$67.7 Million
1.22% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

11.3M
Shares

$46.9 Million
0.03% of portfolio
Black Rock Inc. New York, NY

10.2M
Shares

$42.6 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

9.07M
Shares

$37.7 Million
0.0% of portfolio

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $866M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flower City Capital, based on Form 13F filings with the SEC.

News

Stay updated on Flower City Capital with notifications on news.

Account